SS

Sathya Shanmugaraj Reddiar

Active Director Designated Partner DIN 07612313
DIN 07612313 First appointment Oct 2016 Primary industry Equipment & Machinery
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Sathya Shanmugaraj Reddiar

Data last updated:

Sathya Shanmugaraj Reddiar is a Designated Partner at Harini Pharmatech Llp (since 2016). The company operates in Equipment & Machinery.

DIN 07612313
Primary Designation Designated Partner
Industry Equipment & Machinery
First Appointment 13 Oct 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Oct 20162016Active

Board colleagues of Sathya Shanmugaraj Reddiar

NameDINCompanyDesignation
Shanmugaraj Mahalingam Reddiar03042521Harini Pharmatech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Harini Pharmatech Llp
Premium access

Shareholding and investment profile for Sathya Shanmugaraj Reddiar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sathya Shanmugaraj Reddiar

Sathya Shanmugaraj Reddiar currently holds 1 directorship: Harini Pharmatech Llp (Designated Partner, since 13 Oct 2016).

Sathya Shanmugaraj Reddiar was first appointed on 13 Oct 2016 as Designated Partner at Harini Pharmatech Llp.

The current boards of Sathya Shanmugaraj Reddiar's companies include Shanmugaraj Mahalingam Reddiar (Harini Pharmatech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available